Lexington Delivers 1st Generation HeartSentry for Clinical Trials
13 févr. 2018 09h00 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
Lexington Receives Approval to Commence Clinical Study
24 janv. 2018 09h00 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
Lexington Completes IRB Submission in Preparation for Clinical Study
18 janv. 2018 09h00 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) --
Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device...
Lexington Biosciences Announces Exercise of Warrants
11 janv. 2018 09h00 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
Lexington Hires Medical Device Reimbursement Experts
07 déc. 2017 09h00 HE
|
Lexington Biosciences, Inc.
VANCOUVER, BC--(Marketwired - Dec 7, 2017) - Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the "Company" or "Lexington"), a development-stage medical device company, is pleased to announce...
Lexington Biosciences Engages Clinical Research Organization
30 nov. 2017 09h00 HE
|
Lexington Biosciences, Inc.
VANCOUVER, BC--(Marketwired - Nov 30, 2017) - Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the "Company" or "Lexington"), a development-stage medical device company, is pleased to...
Lexington Biosciences Comments on Recent Trading Activity
01 nov. 2017 21h30 HE
|
Lexington Biosciences, Inc.
VANCOUVER, BC--(Marketwired - Nov 1, 2017) - Lexington Biosciences, Inc. (CSE: LNB) (CSE: LNB.CN) (CNSX: LNB) (OTCQB: LXGTF) (the "Company" or "Lexington") is issuing this press release at the...
Lexington Biosciences Receives HeartSentry Trial Units
23 oct. 2017 07h00 HE
|
Lexington Biosciences, Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct 23, 2017) - Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the "Company" or "Lexington"), a development-stage medical device company, is...
Lexington Biosciences Announces DTC Eligibility of LXGTF Common Shares on OTCQB
25 juil. 2017 09h00 HE
|
Lexington Biosciences, Inc.
VANCOUVER, BC--(Marketwired - Jul 25, 2017) - Lexington Biosciences, Inc. (CSE: LNB) (CNSX: LNB) (OTCQB: LXGTF) (the "Company" or "Lexington"), a development-stage medical device company operating...
Lexington Biosciences Introduces Medical Advisory Board
20 juil. 2017 08h30 HE
|
Lexington Biosciences, Inc.
VANCOUVER, BC--(Marketwired - Jul 20, 2017) - Lexington Biosciences, Inc. (CSE: LNB) (CNSX: LNB) (OTCQB: LXGTF) (the "Company" or "Lexington"), a development-stage medical device company operating...